RxDoctor Payments Data

Roxanna Gunnels, APRN

Family · Carmi, ILNPI 1639778160

Payments from drug & device makers

$1,709in general payments, 2019–2025

Across 110 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$372
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$353
  • AstraZeneca$272
  • AbbVie$232
  • Collegium Pharmaceutical, Inc.$70
  • Axsome Therapeutics, Inc.$57
  • plus $352 from 14 others

What the payments were for

  • Food & beverage$1,709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,709 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$1,086
Medicare patients
29
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,401
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,309
FarxigaDapagliflozin Propanediol11$9,572
EliquisApixaban12$8,285
Albuterol Sulfate HfaAlbuterol Sulfate41$1,142
Solifenacin Succinate12$981
Gabapentin39$340
Atorvastatin Calcium28$319
Alprazolam19$318
Metoprolol Succinate26$311
Buspirone Hcl29$293
Diclofenac Sodium13$277
Cyclobenzaprine Hcl27$240
Rosuvastatin Calcium19$224
Metformin Hcl46$217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$272$20,88229 claims
Lilly USA, LLCMounjaro$13$11,40111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,941 family providers in Illinois.

Other family in Carmi

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →